Galderma, the world's largest independent global dermatology company, was created in 1981 and is now present in over 100 countries with an extensive product portfolio of prescription medicines, aesthetics solutions and consumer care products. The company partners with health care practitioners around the world to meet the skin health needs of people throughout their lifetime. Galderma is a leader in research and development of scientifically-defined and medically-proven solutions for the skin. For more information, please visit www.galderma.com
The ''Head of Investor Relations'' will lead the development and execution of a comprehensive IR, starting with the preparation of our successful IPO and onwards. She/he will report directly to the Group CFO and proactively define and manage relationships with the investment community as well as establish processes and systems to build a well-regarded Investor Relations function.